PLA-PRU-PRU-PLA ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 99 | Chronic intestinal pseudo-obstruction | 1 |
99. Chronic intestinal pseudo-obstruction
Clinical trials : 4 / Drugs : 9 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 4
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00793247 (ClinicalTrials.gov) | December 2008 | 18/11/2008 | Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP) | A Double-Blind, Placebo-Controlled, Cross-Over, Multiple (n=1) Trial to Evaluate the Effects of R093877 in Patients With Chronic Intestinal Pseudo-Obstruction (CIP). | Chronic Intestinal Pseudo-Obstruction | Drug: PRU-PLA-PRU-PLA;Drug: PLA-PRU-PLA-PRU;Drug: PLA-PRU-PRU-PLA;Drug: PRU-PLA-PLA-PRU | Movetis | NULL | Completed | 18 Years | N/A | Both | Phase 2 | United Kingdom |